Litcius/Paper detail

FGFR Inhibitors in Urothelial Cancer: From Scientific Rationale to Clinical Development

Whi‐An Kwon

2024Journal of Korean Medical Science10 citationsDOIOpen Access PDF

Abstract

. This review emphasizes the importance of FGFR inhibition in UC and the optimization of its use in clinical practice. Moreover, it underscores the ongoing efforts to evaluate combination strategies and early treatment testing to enhance the effectiveness of targeted therapies for UC.

Topics & Concepts

Urothelial cancerMedicineMEDLINECancerCancer researchBladder cancerBioinformaticsInternal medicineBiologyBiochemistryBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesFibroblast Growth Factor Research
FGFR Inhibitors in Urothelial Cancer: From Scientific Rationale to Clinical Development | Litcius